CN115354041A - Preparation method of M13 phage single-stranded DNA - Google Patents
Preparation method of M13 phage single-stranded DNA Download PDFInfo
- Publication number
- CN115354041A CN115354041A CN202211276917.5A CN202211276917A CN115354041A CN 115354041 A CN115354041 A CN 115354041A CN 202211276917 A CN202211276917 A CN 202211276917A CN 115354041 A CN115354041 A CN 115354041A
- Authority
- CN
- China
- Prior art keywords
- phage
- stranded dna
- polyethylene glycol
- fermentation
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020004414 DNA Proteins 0.000 title claims abstract description 61
- 102000053602 DNA Human genes 0.000 title claims abstract description 59
- 108020004682 Single-Stranded DNA Proteins 0.000 title claims abstract description 40
- 241001524679 Escherichia virus M13 Species 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 40
- 238000000855 fermentation Methods 0.000 claims abstract description 37
- 230000004151 fermentation Effects 0.000 claims abstract description 28
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 18
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 18
- 241000894006 Bacteria Species 0.000 claims abstract description 11
- 239000006228 supernatant Substances 0.000 claims abstract description 11
- 239000002244 precipitate Substances 0.000 claims abstract description 8
- 230000001376 precipitating effect Effects 0.000 claims abstract description 6
- 238000012258 culturing Methods 0.000 claims abstract description 4
- 241000588724 Escherichia coli Species 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 13
- 239000002609 medium Substances 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 9
- 238000004440 column chromatography Methods 0.000 claims description 8
- 238000005336 cracking Methods 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000012506 Sephacryl® Substances 0.000 claims description 2
- 229920002684 Sepharose Polymers 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 230000008901 benefit Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 description 21
- 230000000694 effects Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 238000012869 ethanol precipitation Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- LBCRWMJTAFCLCL-ZUVMSYQZSA-N 2-[(1e,3e)-4-[6-(methylamino)pyridin-3-yl]buta-1,3-dienyl]-1,3-benzothiazol-6-ol Chemical compound C1=NC(NC)=CC=C1\C=C\C=C\C1=NC2=CC=C(O)C=C2S1 LBCRWMJTAFCLCL-ZUVMSYQZSA-N 0.000 description 3
- 101100409673 Arabidopsis thaliana PBB2 gene Proteins 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 101100301239 Myxococcus xanthus recA1 gene Proteins 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 101150066555 lacZ gene Proteins 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000002823 phage display Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000724791 Filamentous phage Species 0.000 description 1
- 241000721701 Lynx Species 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14051—Methods of production or purification of viral material
- C12N2795/14052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the technical field of biology, in particular to a preparation method of M13mp18 phage single-stranded DNA. The method comprises the following steps: culturing host bacteria until OD value is 10 to 20, and inoculating M13 phage according to MOI of 0.1 to 10 for fermentation culture; centrifuging the co-cultured culture, taking supernatant, ultrafiltering, and precipitating with polyethylene glycol; the precipitate was lysed and purified to obtain M13mp18 phage single stranded DNA. The method greatly improves the expression level of M13 phage single-stranded DNA, and makes up for the disadvantage of low expression level of M13 phage single-stranded DNA in the prior art. The invention reduces the production cost of the M13 phage single-stranded DNA, improves the economic benefit of the M13 phage single-stranded DNA, lays a foundation for the popularization and the application of the DNA nanometer folded paper carrier, and has important significance for preparing the DNA nanometer folded paper carrier in a large scale and improving the economic benefit.
Description
Technical Field
The invention relates to the technical field of biology, in particular to a preparation method of M13 phage single-stranded DNA.
Background
DNA origami is an important branch of DNA nanotechnology. The invention of the method is that hundreds of short single-stranded DNAs are used as staples in 2006 (Nature 2006) to assist in folding a phage genome single-stranded DNA (also called scaffold chain) with the length of thousands of bases, and the phage genome single-stranded DNA is self-assembled to form a pre-designed structure. Among them, the single-stranded DNA carried by M13 phage is one of the most commonly used scaffold strands. The M13 phage is a filamentous phage that contains a circular single-stranded DNA molecule that contains the genetic information required for DNA replication and phage propagation. Wherein M13mp series are used for modifying wild type M13, and a multiple cloning site and a LacZ gene are inserted, so that the DNA sequence template can accommodate exogenous DNA300-400bp, and can be used for preparing a single-stranded template and a nucleic acid probe used in DNA sequencing.
The M13 phage particle is filamentous and infects only F + (containing the F plasmid, capable of producing sexual pili) E.coli. After infection of a host, the host cells are usually not lysed, but rather the phage particles are secreted from the infected cells, and the host cells continue to grow and divide.
When M13 phage single-stranded DNA is prepared in the prior art, M13 virus particles are mainly precipitated by a polyethylene glycol method, and then M13 single-stranded DNA is extracted by organic reagents such as an ethanol precipitation method and a phenol extraction method, so that in the aspect of expression, industrialization cannot be realized by linear amplification of equipment, and the expression level is low; in the aspect of extraction, a large amount of organic reagents are generally required to be used, and pre-cooling at-20 ℃ is often required, so that the requirements of a production workshop on environmental protection, explosion prevention and the like are increased, and the industrial amplification cost and risk are greatly increased.
Disclosure of Invention
In view of the above, the present invention provides a method for preparing single-stranded DNA of M13 bacteriophage. The method greatly improves the yield of the M13 phage single-stranded DNA, reduces the production cost of the ssDNA, is suitable for large-scale preparation of the DNA nano origami carrier, and effectively improves the economic benefit.
In order to achieve the above object, the present invention provides the following technical solutions:
a method for preparing M13 phage single-stranded DNA, comprising:
culturing host bacteria until the OD value is 10 to 20, and inoculating M13 phage according to the MOI of 0.1 to 10 for fermentation culture;
centrifuging the co-cultured culture, taking supernatant, ultrafiltering to change liquid, and precipitating with polyethylene glycol; the precipitate is lysed and purified to obtain M13 phage single-stranded DNA.
In the present invention, the specific type of M13 phage is not particularly limited, and M13 phage commonly used in the art may be used. In a particular embodiment, specifically the M13mp18 bacteriophage.
In the present invention, the host bacterium is Escherichia coli, specifically JM109 strain in the specific example.
In some embodiments, the host bacteria are cultured to an OD of 15 and M13 phage is inoculated.
In some embodiments, the MOI is 0.1.
In the present invention, the medium for the fermentation culture contains 5 to 15mM Mg 2+ And 10 to 15mM Ca 2+ 2 XYT medium.
In some embodiments, the fermentation medium is a medium containing 15mM Mg 2+ And 15mM Ca 2+ 2 XYT medium.
In the invention, the conditions of the fermentation culture are as follows: the temperature is 37 ℃, the pH value is 7.00, the stirring speed is 150 to 650 rpm, and the dissolved oxygen value DO is 20 to 30 percent; the time for fermentation culture is 4h to 5h.
In the present invention, the polyethylene glycol precipitate comprises: taking supernatant, ultrafiltering to obtain filtrate, adding polyethylene glycol and NaCl to make the final concentration of polyethylene glycol be 4-10 wt% and the final concentration of NaCl be 0.5mmol/L, standing, and centrifuging;
the cracking is carried out by alkali; the purification is column chromatography purification, and the adopted purification column is Sephacryl S-500 HR, sepharose 6 FF or Capto Core 700, preferably Capto Core 700;
centrifuging the co-cultured culture, taking supernatant, ultrafiltering, and precipitating with polyethylene glycol; and (5) cracking and purifying the precipitate.
The invention provides a preparation method of M13 phage single-stranded DNA, which comprises the following steps: culturing host bacteria until the OD value is 10 to 20, and inoculating M13 phage according to the MOI of 0.1 to 10 for fermentation culture; centrifuging the co-cultured culture, taking supernatant, ultrafiltering, and precipitating with polyethylene glycol; the precipitate was lysed and purified to obtain M13mp18 phage single stranded DNA. The method greatly improves the expression level of M13 phage single-stranded DNA, and makes up for the disadvantage of low expression level of M13 phage single-stranded DNA in the prior art. The invention reduces the production cost of the M13 phage single-stranded DNA, improves the economic benefit of the M13 phage single-stranded DNA, lays a foundation for the popularization and the application of the M13 phage single-stranded DNA in the DNA nano origami carrier, and has important significance for preparing the DNA nano origami carrier in a large scale and improving the economic benefit.
Drawings
FIG. 1 shows the effect of different infection timings on phage growth;
FIG. 2 shows the effect of different multiplicity of infection (MOI) on phage growth;
FIG. 3 shows the effect of different feeding conditions on phage growth;
FIG. 4 shows the chromatogram of a Capto Core 700 column chromatography purification.
Detailed Description
The invention provides a preparation method of M13 phage single-stranded DNA. Those skilled in the art can modify the process parameters appropriately in view of the disclosure herein. It is expressly intended that all such similar substitutes and modifications which would be obvious to one skilled in the art are deemed to be included in the invention. While the methods and applications of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations and modifications in the methods and applications disclosed herein, or appropriate variations and combinations thereof, may be made to implement and use the techniques of this invention without departing from the spirit and scope of the invention.
Unless otherwise specified, the test materials used in the present invention are all common commercial products and can be purchased in the market.
The invention is further illustrated by the following examples:
example 1 optimization of fermentation parameters for Co-fermentation of M13mp18 phage and host bacteria-timing of infection
1 purpose: and (3) comparing the influence of different infection moments on the growth condition of the phage on a 5L bioreactor, and determining the optimal infection moment.
2 materials and methods
2.1 culture Medium
2 × YT medium: soybean peptone 1.6%, yeast extract 1%, naCl 0.5%, pH7.0.
2.2 Laboratory apparatus
2.2.1 Constant temperature shaking table: shanghai-Heng THI-300C
2.2.2 An ultra-clean workbench: sujingtai SW-CJ-2FD
2.2.3 A pH meter: mettler FE28+ LE438
2.2.4 An ultramicro photometer: denovix DS-11+
2.2.5 An electronic balance scale: shanghai Yueping 3-0.01
2.2.6 An autoclave: shanghai Boxun YXQ-100A
2.2.7 5L fermentation tank: shanghai high-altitude machine B1OF-6005B1G
2.3 test strains
2.3.1 Host bacteria: escherichia coli JM109 Escherichia coli (Migua) Castellani and Chalmers, purchased from American Type Culture Collection (ATCC) and numbered 53323, and stored as Crop Genetics International N.V., and having the genotype F' traD36 proA + proB + lacIq delta (lacZ) M15 delta (lac-proAB) supE44 hsdR17 recA1 gyrA96 thi-1 end A1 relA1 e 14-lambda-.
2.3.2 Phage display: m13mp18
2.4 test methods
2.4.1 The main experimental parameters of the co-fermentation are as follows: the infection time is as follows: the OD values of JM109 E.coli were 10OD, 15 OD and 20OD
2.4.2 Other parameters of the co-fermentation:
2.4.2.1 Multiplicity of infection (MOI): 0.1
2.4.2.1 Temperature: 37 deg.C
2.4.2.2 Stirring speed: 150 to 650 rpm
2.4.2.3 pH value: 7.00
2.4.2.4 Dissolved oxygen value (DO): 25% +/-5%
The temperature, stirring revolution and pH value parameters are automatically adjusted by setting parameters on the interface of the fermentation tank control system. The ventilation volume is determined by a manual regulating valve and a flowmeter and is 2.0 to 8.0L/min. During the culture period, the stirring speed and the aeration rate of the fermentation tank were adjusted. The pH value in the tank is kept at a set value by automatically controlling the acid and alkali supplementation amount in the fermentation process. And sampling every hour to detect the OD600 value of the bacterial liquid, extracting M13 ssDNA according to the extraction method in the molecular cloning experimental guidance, and recording related data.
3 results of the test
The results are shown in Table 1 and FIG. 1.
TABLE 1 Effect of different infection timings on phage growth
Duration of fermentation | 1H | 2H | 3H | | 5H |
OD | |||||
10 | 1.29 | 4.28 | 8.83 | 9.42 | 10.15 |
OD 15 | 5.22 | 15.08 | 18.83 | 19.81 | 21.18 |
OD 20 | 5.77 | 11.41 | 11.42 | 11.63 | - |
Note: the values in the table are cumulative ssDNA yields in mg/L, which is the amount of ssDNA produced per liter of fermentation broth.
4 analysis of results
As shown in Table 1 and FIG. 1, when the infection timing is OD15 OD of JM109 Escherichia coli, the cumulative ssDNA yield is significantly higher than that of the 10OD and 20OD groups, so the infection timing is selected as OD15 to be optimal.
Example 2 optimization of fermentation parameters for Co-fermentation of M13mp18 phage and host bacteria-multiplicity of infection (MOI)
1 purpose: the effect of different plural infection numbers (MOI) on the growth of the phage on a 5L bioreactor was compared and the optimum plural infection number (MOI) was determined.
2 materials and methods
2.1 culture Medium
2 × YT medium: soybean peptone 1.6%, yeast extract 1%, naCl 0.5%, pH7.0.
2.2 Laboratory apparatus
2.2.1 Constant temperature shaking table: shanghai-Heng THI-300C
2.2.2 Superclean bench: sujingtai SW-CJ-2FD
2.2.3 A pH meter: mettler FE28+ LE438
2.2.4 Ultramicro photometers: denovix DS-11+
2.2.5 An electronic balance scale: shanghai Yueping 3-0.01
2.2.6 An autoclave: shanghai Boxun YXQ-100A
2.2.7 5L fermentation tank: shanghai high machine B1OF-6005B1G
2.3 test strains
2.3.1 Host bacteria: escherichia coli JM109 Escherichia coli (Migua) Castellani and Chalmers, purchased from American Type Culture Collection (ATCC) and numbered 53323, and stored as Crop Genetics International N.V., and having the genotype F' traD36 proA + proB + lacIq delta (lacZ) M15 delta (lac-proAB) supE44 hsdR17 recA1 gyrA96 thi-1 end A1 relA1 e 14-lambda-.
2.3.2 Phage display: m13mp18
2.4 test methods
2.4.1 The main experimental parameters of the co-fermentation are as follows: multiplicity of infection (MOI): 0.1, 1, 5, 10
2.4.2 Other parameters of the co-fermentation:
2.4.2.1 The infection time is as follows: the OD value of JM109 Escherichia coli was 15 OD
2.4.2.2 Temperature: 37 deg.C
2.4.2.3 Stirring speed: 150 to 650 rpm
2.4.2.4 pH value: 7.00
2.4.2.5 Dissolved oxygen value (DO): 25% +/-5%
The temperature, stirring revolution and pH value parameters are automatically adjusted by setting parameters on the interface of the fermentation tank control system. The ventilation volume is determined by a manual valve regulation and a flowmeter and is 2.0 to 8.0L/min. During the culture period, the number of stirring revolutions of the fermenter and the amount of aeration were adjusted. The pH value in the tank is kept at a set value by automatically controlling the acid and alkali supplementation amount in the fermentation process. And sampling every hour to detect the OD600 value of the bacterial liquid, extracting M13 ssDNA according to the extraction method of molecular cloning experimental guidance, and recording related data.
Test results
Note: the values in the table are cumulative ssDNA yields in mg/L, i.e., the amount of ssDNA produced per liter of fermentation broth
4 analysis of results
As shown in Table 2 and the data in FIG. 2, cumulative ssDNA yields were significantly higher for 0.1 and 1 infectivity than for 5 and 10 groups, with yields of 0.1 and 1 groups being essentially the same, but with an MOI value of 0.1 being selected as the optimum given that the library size of the phage seed library would be greatly reduced after an order of magnitude reduction in MOI.
Example 3 optimization of fermentation parameters for Co-fermentation of M13mp18 phage and host bacteria-feed conditions
1 purpose: the effect of different feeding conditions on the growth of phage on a 5L bioreactor was compared and the optimal feeding conditions were determined.
2 materials and methods
2.1 reagents
2.1.1 2 × YT medium: soybean peptone 1.6%, yeast extract 1%, naCl 0.5%, pH7.0.
2.1.2 Mg 2+ Ion(s)
2.1.3 Ca 2+ Ion(s)
2.2 Laboratory apparatus
2.2.1 Constant temperature shaking table: shanghai-Heng THI-300C
2.2.2 Superclean bench: sujingtai SW-CJ-2FD
2.2.3 A pH meter: mettler FE28+ LE438
2.2.4 Ultramicro photometers: denovix DS-11+
2.2.5 Electronic balance scale: shanghai Yueping 3-0.01
2.2.6 An autoclave: shanghai Boxun YXQ-100A
2.2.7 5L fermentation tank: shanghai high-altitude machine B1OF-6005B1G
2.3 test strains
2.3.1 Host bacteria: escherichia coli JM109 Escherichia coli (Migua) Castellani and Chalmers, purchased from American Type Culture Collection (ATCC) and numbered 53323, stored as Crop Genetics International N.V., and having the genotype F' traD36 proA + proB + lacIq delta (lacZ) M15 delta (lac-proAB) supE44 hsdR17 recA1 gyrA96 thi-1 end A1 relA1 e14-lambda-.
2.3.2 Phage display: m13mp18
2.4 test methods
2.4.1 Main experimental parameters of co-fermentation: see Table 3 for details
2.4.2 Other parameters of the co-fermentation:
2.4.2.1 The infection time is as follows: the OD value of JM109 Escherichia coli was 15 OD
2.4.2.2 Multiplicity of infection (MOI): 0.1
2.4.2.3 Temperature: 37 deg.C
2.4.2.4 Stirring speed: 150 to 650 rpm
2.4.2.5 pH value: 7.00
2.4.3.6 Dissolved Oxygen (DO): 25% +/-5%
The temperature, stirring revolution and pH value parameters are automatically adjusted by setting parameters on the interface of the fermentation tank control system. The ventilation volume is determined by a manual valve regulation and a flowmeter and is 2.0 to 8.0L/min. During the culture period, the number of stirring revolutions of the fermenter and the amount of aeration were adjusted. The pH value in the tank is kept at a set value by automatically controlling the acid and alkali supplementation amount in the fermentation process. And sampling every hour to detect the OD600 value of the bacterial liquid, extracting M13 ssDNA according to the extraction method in the molecular cloning experimental guidance, and recording related data.
3 results of the test
TABLE 3 Effect of different multiplicity of infection (MOI) on phage growth
|
1 | 2 | 3 | 4 | 5 | ||
Supplementary culture medium | - | - | | 3L | 2× | 3L | 2×YT |
MgCl 2 Concentration of | - | 15mM | 5mM | 15mM | 15mM | ||
CaCl 2 Concentration of | - | 15mM | 10mM | 10mM | 15mM | ||
1H | 0.12 | 0.07 | 0.03 | 4.80 | 0.07 | ||
2H | 12.36 | 12.98 | 13.17 | 21.84 | 11.50 | ||
3H | 24.12 | 22.63 | 34.05 | 39.56 | 25.97 | ||
4H | 29.16 | 25.96 | 41.70 | 44.94 | 49.78 | ||
5H | 33.05 | 32.28 | 50.20 | 55.20 | 58.42 |
Note: the values in the table are cumulative ssDNA yields in mg/L, i.e., the amount of ssDNA produced per liter of fermentation broth
4 analysis of results
As shown in Table 3 and FIG. 3, the fed combination ssDNA used in experiment No. 5 gave the highest yield.
In combination with the above experimental results, it can be determined that the optimal protocol for preparing phage single-stranded DNA of the present invention is the protocol with experiment number 5: the infection time is JM109 Escherichia coli OD value 15, the infection complex number (MOI) is 0.1, and the feeding conditions are as follows: containing 15mmol/LMg 2+ 15mmol/L Ca 2+ 2 XYT medium.
EXAMPLE 4 column chromatography purification of M13 Single stranded DNA
1. The purpose is as follows: and (3) purifying the cracked M13 single-stranded DNA by using Capto Core 700 column chromatography, removing residual host protein and endotoxin, and replacing the traditional ethanol precipitation method.
2. Materials and methods
2.1 Reagent and consumable
2.1.1 A chromatographic column: capto Core 700
2.1.2 Mobile phase: 20mM Tris-HCl,150mM NaCl, pH 8.0
2.1.3 Reagent:
2.1.3.1 PBB2 (50 mL volume)
0.4g NaOH
0.5g SDS
Adding water to 50mL
2.1.3.2 PBB3 (50 mL volume)
12.3g sodium acetate or 14.72g potassium acetate
5.75mL of glacial acetic acid
Adding water to 50mL
2.1.3.3 75% ethanol (-20 ℃ precooling)
2.1.3.4 Anhydrous ethanol (-20 ℃ precooling)
2.2 Laboratory apparatus
2.2.1 A centrifuge: LYNX 4000 hummer flyer
2.2.2 A purification instrument: saipu SDL 100
2.3 Experimental materials: m13 single-stranded DNA (deoxyribonucleic acid) crudely extracted by PEG (polyethylene glycol) method and alkaline cracking method
2.4 Test method
2.4.1 PEG method for extracting M13 particles
2.4.1.1 The method is described in detail in molecular cloning, experimental Manual 4 th edition (supra), scheme 8 polyethylene glycol precipitation method for preparing M13 phage single-stranded DNA, P24-P26.
2.4.2 Alkaline cracking method for extracting M13 single-stranded DNA
2.4.2.1 According to the proportion of PBB2: m13 viral particle solution =1:2, adding the PBB2 solution, stirring the mixture evenly and gently, and then respectively standing the mixture at room temperature for 3min.
2.4.2.2 According to the PBB3: m13 viral particle solution =1: adding PBB3 solution according to the proportion of 1.5, stirring the mixture evenly and softly, and standing the mixture for 10min at the temperature of between 2 and 8 ℃.
2.4.2.3 The mixture was centrifuged at 16500g,30min,4 ℃ and the precipitate was discarded. If the supernatant was cloudy, it was centrifuged once more at 16500g,15min,4 ℃. The supernatant was collected.
2.4.3 Control group: ethanol precipitation method
2.4.3.1 The method is described in molecular cloning instruction 4 th edition (upper volume) scheme 8 polyethylene glycol precipitation method for preparing M13 phage single-stranded DNA, P24-P26.
2.4.4 Experimental groups: capto Core 700 column chromatography
2.4.4.1 The supernatant of the cleaved M13 single-stranded DNA was applied to a Capto Core 700 column.
2.4.4.2 And collecting the flow-through liquid according to the light absorption value of 260nm, wherein the flow-through liquid is used as a target object.
2.4.4.3 Ultraviolet concentration determination, scanning wave band: 230-300 nm. And detecting the host protein and endotoxin residue levels.
3. Test results
3.1 chromatographic results
The chromatographic results are shown in FIG. 4.
3.2 M13 single-stranded DNA recovery and impurity removal levels
TABLE 4
Group of | Yield of M13 Single-stranded DNA | Host protein removal rate | Endotoxin levels |
Control group: ethanol precipitation method | 62.1% | 73.8% | 0.00705≤X<0.07052 |
Experimental groups: the column chromatography of the invention | 85.5% | 95.4% | 0.00041≤X<0.00408 |
4 analysis of results
The results show that the column chromatography method is superior to the traditional ethanol precipitation method in terms of yield, impurity residue level and the like, and the difficulty of the construction of future production workshops is greatly reduced due to the elimination of ethanol.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that it is obvious to those skilled in the art that various modifications and improvements can be made without departing from the principle of the present invention, and these modifications and improvements should also be considered as the protection scope of the present invention.
Claims (10)
1. A method for preparing a single-stranded DNA of M13 phage, comprising:
culturing host bacteria until the OD value is 10 to 20, and inoculating M13 phage according to the MOI of 0.1 to 10 for fermentation culture;
centrifuging the co-cultured culture, taking supernatant, ultrafiltering, and precipitating with polyethylene glycol; the precipitate is lysed and purified to obtain M13 phage single-stranded DNA.
2. The method of producing according to claim 1, wherein the M13 phage is an M13mp18 phage.
3. The method according to claim 1, wherein the host bacterium is Escherichia coli.
4. The method according to claim 3, wherein the Escherichia coli is JM109 strain.
5. The method according to claim 1, wherein the host bacterium is cultured to an OD of 15, and M13 phage is inoculated.
6. The method of claim 1, wherein the MOI is 0.1.
7. The method according to claim 1, wherein the fermentation culture medium contains 5 to 15mM Mg 2+ And 10 to 15mM Ca 2+ 2 XYT medium.
8. The method of claim 4, wherein the fermentation medium comprises 15mM Mg 2+ And 15mM Ca 2+ 2 XYT medium.
9. The method according to claim 1, wherein the conditions of the fermentation culture are:
the temperature is 37 ℃, the pH value is 7.00, the stirring speed is 150 to 650 rpm, and the dissolved oxygen value DO is 20 to 30 percent.
10. The method of claim 1, wherein the polyethylene glycol precipitation comprises: taking supernatant, ultrafiltering to obtain filtrate, adding polyethylene glycol and NaCl to make the final concentration of polyethylene glycol be 4-10 wt% and the final concentration of NaCl be 0.5mmol/L, standing, and centrifuging;
the cracking is carried out by alkali; the purification is column chromatography purification, and the adopted purification column is Sephacryl S-500 HR, sepharose 6 FF or Capto Core 700;
centrifuging the co-cultured culture, taking supernatant, ultrafiltering, and precipitating with polyethylene glycol; and (5) cracking and purifying the precipitate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211276917.5A CN115354041A (en) | 2022-10-19 | 2022-10-19 | Preparation method of M13 phage single-stranded DNA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211276917.5A CN115354041A (en) | 2022-10-19 | 2022-10-19 | Preparation method of M13 phage single-stranded DNA |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115354041A true CN115354041A (en) | 2022-11-18 |
Family
ID=84008949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211276917.5A Pending CN115354041A (en) | 2022-10-19 | 2022-10-19 | Preparation method of M13 phage single-stranded DNA |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115354041A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0431905A1 (en) * | 1989-12-06 | 1991-06-12 | Tosoh Corporation | Method for purifying phage DNA |
CN101921734A (en) * | 2010-09-09 | 2010-12-22 | 天津科技大学 | Method for purifying phage through chromatography |
CN109371011A (en) * | 2018-11-26 | 2019-02-22 | 天津科技大学 | A method of new extraction phage genome DNA |
CN110699407A (en) * | 2019-10-17 | 2020-01-17 | 复旦大学附属肿瘤医院 | Preparation method of long single-strand DNA |
CN113278607A (en) * | 2021-04-20 | 2021-08-20 | 南京大学 | Preparation method of circular single-stranded DNA integrated by nucleic acid aptamer and application of circular single-stranded DNA integrated by nucleic acid aptamer in DNA paper folding |
CN113337480A (en) * | 2021-06-30 | 2021-09-03 | 华中农业大学 | Broad-spectrum coliphage and application thereof |
-
2022
- 2022-10-19 CN CN202211276917.5A patent/CN115354041A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0431905A1 (en) * | 1989-12-06 | 1991-06-12 | Tosoh Corporation | Method for purifying phage DNA |
CN101921734A (en) * | 2010-09-09 | 2010-12-22 | 天津科技大学 | Method for purifying phage through chromatography |
CN109371011A (en) * | 2018-11-26 | 2019-02-22 | 天津科技大学 | A method of new extraction phage genome DNA |
CN110699407A (en) * | 2019-10-17 | 2020-01-17 | 复旦大学附属肿瘤医院 | Preparation method of long single-strand DNA |
CN113278607A (en) * | 2021-04-20 | 2021-08-20 | 南京大学 | Preparation method of circular single-stranded DNA integrated by nucleic acid aptamer and application of circular single-stranded DNA integrated by nucleic acid aptamer in DNA paper folding |
CN113337480A (en) * | 2021-06-30 | 2021-09-03 | 华中农业大学 | Broad-spectrum coliphage and application thereof |
Non-Patent Citations (7)
Title |
---|
A. RITA SILVA-SANTOS等: "Scalable purification of single stranded DNA scaffolds for biomanufacturing DNA-origami nanostructures: Exploring anion-exchange and multimodal chromatography", 《SEPARATION AND PURIFICATION TECHNOLOGY》 * |
CYTIVA思拓凡: "质粒纯化两步法详解", 《"CYTIVA思拓凡"微信公众号》 * |
M.R.格林等: "《分子克隆实验指南 原书第4版》", 31 March 2017 * |
卢圣栋等: "《现代分子生物学实验技术 第2版》", 31 December 1999 * |
张申等: "《分子生物学检验 新版》", 31 January 2017 * |
王晓辉: "DNA折纸结构表面聚合物膜的制备及表征", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 * |
陈润: "适配体特异性修饰DNA纳米治疗系统抗肿瘤作用研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106520866B (en) | Method for improving yield of erythromycin by modifying saccharopolyspora erythraea SACE _3980 gene | |
CN113881586B (en) | High-temperature-resistant, high-sugar-resistant and high-salt-resistant saccharomyces cerevisiae strain as well as construction method and application thereof | |
CN114369613A (en) | Yeast strain for constructing high-yield CBGA synthesis by modifying galactose promoter and construction method and application thereof | |
CN112522300A (en) | Method for cultivating broad-spectrum bacterial leaf streak resistant rice, primer and expression cassette | |
CN114410560B (en) | Engineering strain for high-yield FK228 and construction and application thereof | |
CN109593892A (en) | A kind of universal primer group, kit and method expanding H5N6 subtype avian influenza virus full-length genome | |
CN115354041A (en) | Preparation method of M13 phage single-stranded DNA | |
CN112342214A (en) | sgRNA sequence for targeted knockout of channel catfish zbtb38 gene and screening method thereof | |
CN109136253B (en) | Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _5754 gene approach | |
CN110628788A (en) | Construction method of monascus purpureus comp51725_ c0 gene overexpression strain | |
CN110684795A (en) | Construction method of monascus purpureus comp50904_ c4 gene overexpression strain | |
CN110628725A (en) | Citrus yellowed vein clearing virus mutant and construction method thereof | |
CN113564093B (en) | Escherichia coli and application thereof in high-yield preparation of D-proline | |
CN116064905A (en) | Primer combination for detecting verticillium dahliae, kit and application | |
CN115838405A (en) | Wheat stripe rust resistance related protein TaBURP1 and coding gene and application thereof | |
CN113667688A (en) | Trichoderma longibrachiatum plasmid vector and construction method and application thereof | |
CN117683755B (en) | C-to-G base editing system | |
CN112442510A (en) | Construction method of glucose-resistant high-secretion type genetic engineering receptor bacterium | |
CN113684191A (en) | Pear head mould steroid 11 beta-hydroxylase CYP5311B2 mutant construction and application thereof | |
CN114507684B (en) | Method for inhibiting target gene expression in Mediterranean salt-rich bacteria | |
CN116064596A (en) | Saccharomyces cerevisiae multidrug resistance transcription factor gene YRR mutant YRR1 T185A And applications thereof | |
CN114622031B (en) | SNP locus and CAPS molecular marker primer pair for identifying thousand seed weight characteristics of wheat and application of SNP locus and CAPS molecular marker primer pair | |
CN104263748A (en) | Biological engineering strain, and preparation method and application thereof | |
CN117904162A (en) | Method for improving erythromycin yield by modifying rhodosporidium saccharatum SACE_5680 gene and application | |
CN118006609A (en) | Idesia polycarpa U6 promoter and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221118 |